Vaccines Against Virally Induced Cancers: No. 187 (Novartis Foundation Symposia) - Image 1

£90.00

Wiley-Blackwell Vaccines Against Virally Induced Cancers: No. 187 (Novartis Foundation Symposia)

Name: Vaccines Against Virally Induced Cancers: No. 187 (Novartis Foundation Symposia)
Brand: Wiley-Blackwell
Price: 90.0 GBP
Availability: InStock

Immunology

This is the most expensive it has ever been. Walk away.

£90 today · previous high £90 · all-time low £43

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days • 70 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 70 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £43 (55 days, 78.6%)

Price range: £43 - £90

Price levels: 2 different prices over 70 days

Description

Vaccines Against Virally Induced Cancers Chairman: Ian Frazer 1994 Viruses are responsible for approximately 15 per cent of human cancers worldwide. Epstein - Barr virus is believed to be associated with Burkitt's lymphoma, a type of nose and throat cancer that kills 40 000 people each year. The human papillomaviruses are associated with cervical and other genital cancers; hepatitis B virus increases the risk of liver cancer 200-fold. An effective vaccine against hepatitis B virus is available, but it has no effect on hepatocellular cancer. Many virally induced cancers express viral gene products, so a cytotoxic T cell response specific for the viral antigen could kill the tumour cells. There is an urgent need for vaccines against these types of cancer. This book describes various strategies to develop such vaccines. In some cases the viral proteins expressed by the tumours are known; these are recognized by T cells in vitro, but viruses have evolved diverse strategies for evading host immune responses. Investigation of these viral defence mechanisms and development of ways to overcome them are major areas of current research. Immunotherapy by transfer of cytotoxic T lymphocytes stimulated in culture to recognize tumour-specific markers and transfection of tumour cells with genes for cytokines to improve their immunogenicity have both been successful in experimental animals. Another approach using purified virus or viral subunits has led to effective vaccines against animal papillomaviruses. It is hoped that versions of all these vaccines for use in humans will be available in the near future. Other Ciba Foundation Symposia: No. 141 Metastasis Chairman: I J Fidler 1988 ISBN 0 471 91513 0 No. 186 Antimicrobial peptides Chairman: Hans G Boman 1994 ISBN 0 471 95025 4 No. 189 Cell adhesion and human disease Chairman: Richard O Hynes 1995 ISBN 0 471 95279 6

Product Specifications

Brand: Wiley-Blackwell
Format: hardcover
ASIN: 0471950262
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Immunology
Domain: Amazon UK
Release Date: 22 November 1994
Listed Since: 22 January 2007

Barcode

No barcode data available

Wiley-Blackwell Vaccines Against Virally Induced Cancers: No. 187 (Novartis Foundation Symposia)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Papillomaviruses (Novartis Foundation Symposia)

The Papillomaviruses

Infectious Agents and Cancer

Human Papillomavirus Vaccines

HPV and Cervical Cancer: Achievements in Prevention and Future Prospects

Viruses and Human Cancer

Hepatitis B: The Virus, the Disease, and the Vaccine

Papillomaviruses and Human Disease

Medical Virology 8

Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)

Epstein-Barr Virus and Human Disease: 15 (Experimental Biology and Medicine, 15)

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Hepatitis B Virus and Liver Disease

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Vaccine Protocols: 87 (Methods in Molecular Medicine, 87)

Recombinant Virus Vaccines: Methods and Protocols: 1581 (Methods in Molecular Biology, 1581)

New Vaccines and Chemotherapy: 1 (Annals of Theoretical Psychology, 1)

Cancers in People with HIV and AIDS: Progress and Challenges

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

HIV & HTLV-I Associated Malignancies: 104 (Cancer Treatment and Research, 104)

Cancer in Transplantation: Prevention and Treatment: Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995: 27

Immunosuppression and Human Malignancy (Contemporary Immunology)